News for Syngene International Limited (SYNGENE.BO)

Following Trump's tariff pause in April 2025, the Nifty Healthcare index rebounded strongly, rising 7%. Mutual funds increased holdings in several healthcare stocks, with Syngene International seeing the highest buying. While some stocks like Zydus Lifesciences faced sell-offs, the sector's overall performance remained robust, outperforming the Nifty.

Apr 24, 2025 / 05:30AM GMTOperator Ladies and gentlemen, good day and welcome to Q4 and full year ended March 2025 financial results conference call of Syngene

Markets traded range-bound on April expiry day amid global selling pressure and weak FMCG earnings; analysts expect continued consolidation and advise stock-specific buying on dips.

Indian equity markets suffered a brutal decline on Monday extending their losses for a third consecutive session, amid a global rout triggered by escalating trade tensions. The Nifty Midcap 100 plummeted 7.26% to 46,966.60—its lowest level in a month—as panic gripped investors across sectors following a steep sell-off in global equities.

Stocks including Tata Steel, Power Grid, Tata Consumer Products, Coal India, NMDC, JSW Energy, RITES, Siemens, Hindustan Copper will be in the spotlight on Wednesday, April 02.

PR NewswireBANGALORE, India, March 10, 2025 Expected to enhance global innovator flexibility with biologics drug substance facility in BaltimoreBANGALORE,

Syngene International acquires US manufacturing facility, expanding bioreactor capacity and global service capabilities for pharmaceutical innovation.

**media[545950]**

Indian benchmark indices ended lower on Friday, led by declines in pharma, real estate, and auto stocks. Capri Global, KFin Technologies, and Mphasis reported strong earnings, while Cyient and Tejas Networks saw sharp drops.

Syngene International Limited reports strong Q3 results with profit-after-tax of Rs 131 crore and revenue growth of 11%.

Stocks including Hindustan Unilever, Stallion India, UltraTech, BPCL, Laurus Labs, Go digit, Adani Green and more will be in the spotlight on Thursday, January 23.

Eicher Motors Ltd., BSE Ltd., ABB India Ltd., Larsen & Toubro Ltd. and Titan Co. are among the companies that Jefferies expects will post strong third quarter earnings this season, amid a dim forecast for broader India Inc. Jefferies projects earnings growth for companies in its coverage, excluding oil and gas and metals, to decline by two percentage points on a sequential basis to an 18-quarter low of 8% year-on-year on a sharp slowdown in lending financial earnings.

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.

Biocon Ltd. sells 80 lakh Syngene shares in a Rs 686 crore block deal, retaining a 52.46% stake. The sale supports strategic alignment amid challenges in Q2 FY25.

Stocks including Tata Motors, Syngene, JSW Steel, Bharat Electronics, Vodafone Idea, Bharat Forge, NHPC, Torrent Power and more will be in the spotlight on Tuesday, December 10.

Shares of Syngene International dropped 5.7%, Piramal Pharma fell 4.2%, Lauras Labs and Neuland Laboratories declined 3% and Divi's Laboratories fell 2.8% on Monday. The BSE 500 was down 0.1%.

Syngene CFO Sibaji Biswas resigns, Deepak Jain to take over; Jayashree Aiyar appointed CSO, driving scientific strategy and innovation.

The global preclinical CRO market size was valued at USD 8.62 billion in 2024. It is projected to reach USD 21.48 billion by 2033, growing at a CAGR of...

OneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopharma, was demerged from Strides Pharma and aims to list on BSE and NSE within a year. OneSource plans to reduce debt and expand its manufacturing capabilities.